Goldman Sachs’s Anebulo Pharmaceuticals ANEB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16.7K Sell
11,600
-36,354
-76% -$52.4K ﹤0.01% 5058
2025
Q1
$62.3K Buy
+47,954
New +$62.3K ﹤0.01% 4892